Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkins Lymphoma
Cephalon, 11/06/09

Cephalon, Inc. announced the journal Cancer has published a pivotal study demonstrating that TREANDA (bendamustine HCl) for Injection induced durable responses in patients with indolent B–cell non–Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.

Today in Research & Development...keeping you current

HealthPort Postpones its IPO
HealthDataManagement, 11/25/09

Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/24/09

 See all of Research & Development

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address